Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

780 questions · 834 findings · 76 reviews

No studies found 187 · 22.4%GRADE not reported 164 · 19.7%Very low 144 · 17.3%Low 172 · 20.6%Moderate 105 · 12.6%High 62 · 7.4%

Higher maternal circulating 25-hydroxyvitamin D (25(OH)D) concentration vs Lower maternal circulating 25-hydroxyvitamin D (25(OH)D) concentration

Small‐for‐gestational age · pregnant women and their infants..

Meta-analysis of observational studies (higher vs lower maternal 25(OH)D) for Small for gestational age: OR 0.54 (95% CI 0.44 to 0.67), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.

1 finding from 1 review

Higher maternal circulating 25-hydroxyvitamin D (25(OH)D) concentration vs Lower maternal circulating 25-hydroxyvitamin D (25(OH)D) concentration

Pre‐eclampsia · pregnant women and their infants..

Meta-analysis of observational studies (higher vs lower maternal 25(OH)D) for Pre-eclampsia: OR 0.56 (95% CI 0.39 to 0.80), statistically significant. Umbrella review outcome-level evidence grade: No conclusion.

1 finding from 1 review

Higher maternal circulating 25-hydroxyvitamin D (25(OH)D) concentration vs Lower maternal circulating 25-hydroxyvitamin D (25(OH)D) concentration

Head circumference (mm) · pregnant women and their infants..

Meta-analysis of observational studies (higher vs lower maternal 25(OH)D) for Head circumference: WMD 0.05 (95% CI -0.24 to 0.34), not statistically significant. Umbrella review outcome-level evidence grade: Suggestive.

1 finding from 1 review

Higher maternal circulating 25-hydroxyvitamin D (25(OH)D) concentration vs Lower maternal circulating 25-hydroxyvitamin D (25(OH)D) concentration

Birth length · pregnant women and their infants..

Meta-analysis of observational studies (higher vs lower maternal 25(OH)D) for Birth length: WMD 0.19 (95% CI -0.26 to 0.65), not statistically significant. Umbrella review outcome-level evidence grade: Substantial effect unlikely.

1 finding from 1 review

Higher maternal circulating 25-hydroxyvitamin D (25(OH)D) concentration vs Lower maternal circulating 25-hydroxyvitamin D (25(OH)D) concentration

Birthweight (g) · pregnant women and their infants..

Meta-analysis of observational studies (higher vs lower maternal 25(OH)D) for Birth weight: WMD 130.9 (95% CI 75.1 to 186.7), statistically significant. Umbrella review outcome-level evidence grade: Probable.

1 finding from 1 review

Higher maternal circulating 25-hydroxyvitamin D (25(OH)D) concentration vs Lower maternal circulating 25-hydroxyvitamin D (25(OH)D) concentration

Gestational diabetes · pregnant women and their infants..

Meta-analysis of observational studies (higher vs lower maternal 25(OH)D) for Gestational diabetes: OR 0.67 (95% CI 0.53 to 0.85), statistically significant. Umbrella review outcome-level evidence grade: Suggestive.

1 finding from 1 review

Vitamin C vs allopurinol

Joint pain reduction ‐ not reported · participants with chronic gout and sUA level > 0.36mmol/L

The review found no eligible studies for this question.

1 finding from 1 review

Vitamin C vs allopurinol

Participant global assessment · participants with chronic gout and sUA level > 0.36mmol/L

The review found no eligible studies for this question.

1 finding from 1 review

Vitamin C vs allopurinol

Tophus regression · participants with chronic gout and sUA level > 0.36mmol/L

The review found no eligible studies for this question.

1 finding from 1 review

Vitamin C vs allopurinol

Acute gout attacks · participants with chronic gout and sUA level > 0.36mmol/L

The review found no eligible studies for this question.

1 finding from 1 review

Vitamin A vs placebo

Incidence: lung cancer · healthy people and healthy male physicians

Vitamin A showed no clear difference in incidence: lung cancer compared with placebo (high certainty).

1 finding from 1 review

Vitamin C vs placebo

Incidence: lung cancer ‐ women · healthy male physicians, period: 1997 to 2007 and female health professionals, period: 1998 to 2005

Vitamin C leads to higher incidence: lung cancer ‐ women compared with placebo (high certainty).

1 finding from 1 review

Vitamin C vs placebo

Mortality: lung cancer ‐ men · healthy male physicians, period: 1997 to 2007 and female health professionals, period: 1998 to 2005

Vitamin C showed no clear difference in mortality: lung cancer ‐ men compared with placebo (high certainty).

1 finding from 1 review

Vitamin C vs placebo

Incidence: all cancers · healthy male physicians, period: 1997 to 2007 and female health professionals, period: 1998 to 2005

Vitamin C showed no clear difference in incidence: all cancers compared with placebo (high certainty).

1 finding from 1 review

Vitamin C vs placebo

Mortality: all cancers · healthy male physicians, period: 1997 to 2007 and female health professionals, period: 1998 to 2005

Vitamin C showed no clear difference in mortality: all cancers compared with placebo (high certainty).

1 finding from 1 review

Vitamin A vs placebo

Mortality: lung cancer · healthy people and healthy male physicians

Vitamin A showed no clear difference in mortality: lung cancer compared with placebo (high certainty).

1 finding from 1 review